These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 29671161)

  • 1. Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management.
    Czaja AJ
    Dig Dis Sci; 2018 Jul; 63(7):1706-1725. PubMed ID: 29671161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis.
    Czaja AJ
    World J Gastroenterol; 2016 Nov; 22(42):9257-9278. PubMed ID: 27895415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions.
    Czaja AJ
    World J Gastroenterol; 2019 Dec; 25(45):6579-6606. PubMed ID: 31832000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leaky Gut Driven by Dysbiosis Augments Activation and Accumulation of Liver Macrophages
    Zhang H; Liu M; Zhong W; Zheng Y; Li Y; Guo L; Zhang Y; Ran Y; Zhao J; Zhou L; Wang B
    Front Immunol; 2021; 12():624360. PubMed ID: 33841405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis.
    Czaja AJ
    Autoimmunity; 2019 Jun; 52(4):144-160. PubMed ID: 31298041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis.
    Lin R; Zhou L; Zhang J; Wang B
    Int J Clin Exp Pathol; 2015; 8(5):5153-60. PubMed ID: 26191211
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Zhang H; Liu M; Liu X; Zhong W; Li Y; Ran Y; Guo L; Chen X; Zhao J; Wang B; Zhou L
    Front Immunol; 2020; 11():569104. PubMed ID: 33123141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b-/- mice favoring autoimmune cholangitis.
    Concepcion AR; Salas JT; Sáez E; Sarvide S; Ferrer A; Portu A; Uriarte I; Hervás-Stubbs S; Oude Elferink RP; Prieto J; Medina JF
    Oncotarget; 2015 Oct; 6(30):28588-606. PubMed ID: 26396175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celiac Disease and Liver Disorders: From Putative Pathogenesis to Clinical Implications.
    Hoffmanová I; Sánchez D; Tučková L; Tlaskalová-Hogenová H
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell mediators of autoimmune hepatitis and their therapeutic implications.
    Montano-Loza AJ; Czaja AJ
    Dig Dis Sci; 2015 Jun; 60(6):1528-42. PubMed ID: 25487192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis.
    Czaja AJ; Montano-Loza AJ
    Dig Dis Sci; 2019 Feb; 64(2):324-344. PubMed ID: 30370494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part II.
    Czaja AJ
    Inflamm Allergy Drug Targets; 2012 Oct; 11(5):351-63. PubMed ID: 22563780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving paradigm of treatment for autoimmune hepatitis.
    Czaja AJ
    Expert Rev Clin Immunol; 2017 Aug; 13(8):781-798. PubMed ID: 28406324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal microbiome and permeability in patients with autoimmune hepatitis.
    Cai W; Ran Y; Li Y; Wang B; Zhou L
    Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):669-673. PubMed ID: 29566910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
    Zierden M; Kühnen E; Odenthal M; Dienes HP
    Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T Cells in Autoimmune and Viral Chronic Hepatitis.
    Lapierre P; Lamarre A
    J Immunol Res; 2015; 2015():479703. PubMed ID: 26106627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis of autoimmune hepatitis].
    Maamouri N; Ouerghi H; Belkahla N; Cheikh I; Ben Ammar A
    Tunis Med; 2004 Sep; 82(9):799-804. PubMed ID: 15693472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota in autoimmunity: potential for clinical applications.
    Kim D; Yoo SA; Kim WU
    Arch Pharm Res; 2016 Nov; 39(11):1565-1576. PubMed ID: 27444041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intestinal microbiota and microenvironment in liver.
    Ma HD; Wang YH; Chang C; Gershwin ME; Lian ZX
    Autoimmun Rev; 2015 Mar; 14(3):183-91. PubMed ID: 25315744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.
    Czaja AJ
    Dig Dis Sci; 2015 Oct; 60(10):2881-900. PubMed ID: 25999246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.